INBP Stock Integrated BioPharma (INBP, $0.31) Stochastic Oscillator left the overbought zone on November 19, 2025
at Tickeron.com
This is a signal that INBP's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position. A.I.dvisor identified 73 similar cases where INBP's stochastic oscillator exited the overbought zone, and of them led to successful outcomes. Odds of Success:
INBP's Stochastic Oscillator reaching into overbought zone
The Stochastic Oscillator for INBP moved into overbought territory on November 19, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for INBP crossed bearishly below the 50-day moving average on November 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INBP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INBP's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 19, 2025. You may want to consider a long position or call options on INBP as a result. In of 129 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for INBP just turned positive on November 19, 2025. Looking at past instances where INBP's MACD turned positive, the stock continued to rise in of 63 cases over the following month. The odds of a continued upward trend are .
INBP moved above its 50-day moving average on November 17, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INBP advanced for three days, in of 95 cases, the price rose further within the following month. The odds of a continued upward trend are .
INBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 85 cases where INBP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INBP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.470) is normal, around the industry mean (38.522). P/E Ratio (15.499) is within average values for comparable stocks, (80.379). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.831). INBP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (0.182) is also within normal values, averaging (139.677).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Advertisement
General Information
Industry FoodMajorDiversified